Peptide vaccines in cancer—old concept revisited
T Kumai, H Kobayashi, Y Harabuchi, E Celis - Current opinion in …, 2017 - Elsevier
Synthetic peptide vaccines aim to elicit and expand tumor-specific T cells capable of
controlling or eradicating the tumor. Despite the high expectations based on preclinical
studies, the results of clinical trials using peptide vaccines have been disappointing. Thus,
controlling or eradicating the tumor. Despite the high expectations based on preclinical
studies, the results of clinical trials using peptide vaccines have been disappointing. Thus,
For custom peptides, please visit www.pepmic.com. Our peptide services including but not limited to:
*Peptide Synthesis: From short peptides to long peptides, linear peptides to cyclic peptides.
*Peptide Modifications: Peptide-protein conjugation, D-amino acid peptides, isotope peptides, fluorescent peptides, multiple antigen peptides, multiple disulfide bridge peptides, phosphopeptides etc.
*Catalog Peptides: ACE Inhibitors, Amyloids & Related Peptides, Antimicrobial Peptides, Apelin Peptides, Myelin Oligodendrocyte Glycoprotein (MOG) Peptides, TAT Proteins etc.
*Peptide Salt: TFA, Desalt, Acetate, HCl.
*Peptide Purity: From crude to ＞99.5%.
*Production Capacity: From mg to kg, with a capacity of synthesizing 15,000 peptides/month.
*Peptide Library Synthesis: Alanine Scan, Overlapping, Positional Scan, T-cell Truncated, Scrambled ect.
Quick Links:
Contact Information:
Eva He
eva@pepmic.com
Pepmic Co., Ltdeva@pepmic.com
www.pepmic.com
没有评论:
发表评论